Drugs that contain Albuterol Sulfate
1. Drug name - PROAIR DIGIHALER
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7540282 | TEVA BRANDED PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(6 months from now) | |
| US10765820 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(2 years from now) | |
| US9463288 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(2 years from now) | |
| US8651103 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
Mar, 2028
(5 years from now) | |
| US10124131 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(8 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(8 years from now) | |
| US9731087 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(8 years from now) | |
| US9216260 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(8 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(9 years from now) | |
| US8978966 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(9 years from now) | |
| US9782550 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
| US9782551 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
| US10918816 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(13 years from now) | |
| US10569034 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(13 years from now) | |
| US11000653 | TEVA BRANDED PHARM | Inhaler |
Dec, 2038
(16 years from now) | |
| US11173259 | TEVA BRANDED PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(17 years from now) | |
Treatment: NA
Dosage: POWDER, METERED;INHALATION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.09MG BASE/INH | POWDER, METERED;INHALATION | Prescription |
2. Drug name - PROAIR HFA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7105152 | TEVA BRANDED PHARM | Suspension aerosol formulations |
Sep, 2023
(11 months from now) | |
| US8132712 | TEVA BRANDED PHARM | Metered-dose inhaler |
Sep, 2028
(5 years from now) | |
| US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(8 years from now) | |
| US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(8 years from now) | |
| US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(8 years from now) | |
| US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(8 years from now) | |
| US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(8 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(8 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(9 years from now) | |
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.09MG BASE/INH | AEROSOL, METERED;INHALATION | Prescription |
3. Drug name - VENTOLIN HFA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7832351 | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Jun, 2023
(8 months from now) | |
|
US7832351
(Pediatric) | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Dec, 2023
(1 year, 2 months from now) | |
| US7500444 | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Feb, 2026
(3 years from now) | |
|
US7500444
(Pediatric) | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Aug, 2026
(3 years from now) | |
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.09MG BASE/INH | AEROSOL, METERED;INHALATION | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.